After being in denial about his prostate cancer diagnosis, James Ridley finally decided to become his own advocate and began doing exhaustive research on alternatives to surgery. Read More

Blood work can provide a host of valuable health-related information. But can it detect cancer? Click here to find out. Read More

Advanced age is the most important risk factor for cancer overall. Click here to find out why and learn about the most common cancers among the elderly. Read More

Many early signs of cancer in men may seem minor or go unnoticed. That’s why it’s important for all men to be proactive about their health. Read More

Together, immune content and Decipher scores can help determine which patients could benefit from targeted therapies Read More

Moffitt Cancer Center researchers say immune response differences could be exploited for personalized treatment options Read More

The cancer center opened its VanDAAM prostate cancer study at Bay Pines VA Healthcare System and James A. Haley Veterans’ Hospital with plans for more in the future Read More

New study suggests midlife PSA testing is key to predicting aggressive prostate cancer Read More

The fourth one on the list of Moffitt research developments for 2017 involves rethinking drug resistance with a strategy called adaptive therapy that links the frequency, dosage and type of chemo to the tumor’s response. Read More

New study shows adaptive therapy can prolong treatment benefit and hinder drug resistance in patients with metastatic prostate cancer Read More

Dr. Lodovico Balducci’s research focuses on cancer and aging Read More

George Kondas is a hero, an inspiration and a reminder to never give up hope as America remembers the 75th anniversary of the attack on Pearl Harbor. Read More

In the United States, one in seven men will be affected by prostate cancer at some point during their lives. However, the condition can often be detected early, and when it is, there is significant hope. Read More